Not applicableStudy completedNCT02950168What this trial is testingEdoxaban Management in Diagnostic and Therapeutic ProceduresWho this might be right forAtrial FibrillationVenous Thromboembolism Daiichi Sankyo 1,197
Testing effectiveness (Phase 2)Ended earlyNCT04593784What this trial is testingStudy of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy AdultsWho this might be right forHealthy AMAG Pharmaceuticals, Inc. 41
Not applicableStudy completedNCT03182218What this trial is testingPeriprocedural Direct Oral Anticoagulant ManagementWho this might be right forPeriprocedural Complication Fundación para la Investigación del Hospital Clínico de Valencia 1,100
Not applicableLooking for participantsNCT06431789What this trial is testingProspective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal InsufficiencyWho this might be right forGene PolymorphismEdoxabanRenal Insufficiency Yi Han 220
Not applicableStudy completedNCT04594915What this trial is testingEvaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in TurkeyWho this might be right forAtrial Fibrillation Daiichi Sankyo Turkey, a Daiichi Sankyo Company 1,053
Not applicableNot Yet RecruitingNCT07116239What this trial is testingEdoxaban Steady-State PK/PD in Adults With Nephrotic SyndromeWho this might be right forNephrotic SyndromeHypoalbuminemia Peking University People's Hospital 60
Not applicableLooking for participantsNCT02219984What this trial is testingSTART-Register: Survey on Anticoagulated Patients RegisterWho this might be right forAtrial FibrillationVenous ThromboembolismHeart Valve Diseases or Prosthesis GUALTIERO PALARETI 15,410
Not applicableStudy completedNCT04121767What this trial is testingSafety and Efficacy of Edoxaban in Thoracoscopic AblationWho this might be right forAtrial FibrillationAnticoagulants and Bleeding Disorders Samsung Medical Center 60
Large-scale testing (Phase 3)Study completedNCT03996772What this trial is testingPREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial FibrillationWho this might be right forAtrial FibrillationIntracerebral Hemorrhage Imperial College London 319
Not applicableNot Yet RecruitingNCT05764356What this trial is testingImapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study IIWho this might be right forNovel Oral AnticoagulantsNOACsRivaroxaban+9 more Peking University First Hospital 2,000
Post-approval studies (Phase 4)Study completedNCT04072068What this trial is testingStudy on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic TherapyWho this might be right forThromboembolismCancer Gruppo Oncologico Italiano di Ricerca Clinica 150
Not applicableUnknownNCT03271450What this trial is testingThe DARE Warfarin CER StudyWho this might be right forDeep Venous ThrombosisPulmonary Embolism Brigham and Women's Hospital 416,000
Not applicableStudy completedNCT06930937What this trial is testingTo Compare and Evaluate the Oral Bioavailability of Edoxaban 60 mg Film Coated Tablet With That of Lixiana® 60 mg Filmtabletten (Film Coated Tablet) (Edoxaban) in Healthy, Adult, Human Subjects Under Fasting ConditionsWho this might be right forPrevention of Stroke or Systemic EmbolismDeep Vein Thrombosis (DVT)Pulmonary Embolism (PE) Humanis Saglık Anonim Sirketi 42
Post-approval studies (Phase 4)Ended earlyNCT02561897What this trial is testingEdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial FibrillationWho this might be right forAtrial Fibrillation Electrophysiology Research Foundation 5
Not applicableStudy completedNCT02964949What this trial is testingComparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical OutcomesWho this might be right forAtrial Fibrillation Daiichi Sankyo 607
Large-scale testing (Phase 3)Study completedNCT02866175What this trial is testingEdoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary InterventionWho this might be right forAtrial Fibrillation Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 1,506
Not applicableStudy completedNCT03488420What this trial is testingCanadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasEWho this might be right forAtrial Fibrillation and FlutterValvular Heart Disease Montreal Heart Institute 136
Not applicableEnrolling By InvitationNCT07242326What this trial is testingSNAP AF-52: Dose Appropriateness and Adherence to Oral Anticoagulation in Adults ≥65 With Atrial Fibrillation in Primary Care (Ordu, Türkiye)Who this might be right forMedication AdherenceAtrial Fibrillation (AF)Direct Oral Anticoagulants (DOACs) Kotyora Family Medicine Health Management and Education Association 1,000
Large-scale testing (Phase 3)UnknownNCT03570281What this trial is testingEdoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study)Who this might be right forCorrection of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban) Samsung Medical Center 40
Not applicableUnknownNCT03554837What this trial is testingSafety and Effectiveness of Low Dose Edoxaban in Patients With NVAFWho this might be right forAtrial Fibrillation Samsung Medical Center 2,562